MUTYH and neoplasm: The contrast of these findings with our previous sub-cutaneous model, which showed MYH knockdown significantly reduced tumour growth, can be explained by the lack of CAFs and the sub-cutaneous location of our prior model, as well as the shorter time frame and intratumoural route for treatment .4